Recent Finacing
Recent Raise
Elevian is a biotech developing recombinant human GDF11 therapies to restore regenerative capacity, advancing rGDF11 toward IND and Phase I trials while developing proteins, antibodies and small molecules.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Elevian.
